Bright Minds 10/13

Oct 26, 2023

Bright Minds

Breakfast at biolabs: BioNTX

BioNTX CEO Kathleen Otto gives us a summary of the biotech activity in North Texas.

Stifel Analyst Alex Thompson joins BiotechTV for Analyst Thursdays

Oct 26, 2023

Bright Minds

Stifel Analyst Alex Thompson joins BiotechTV for Analyst Thursdays

Alex Thompson gives a deep dive into the I&I space and discusses Apogee, Aeglea, argenx, Immunovant, Aclaris, Morphic, and Ventyx.

Oct 26, 2023

Bright Minds

Breakfast at biolabs: GenrAb

Larry Tiffany describes how GenrAb is leveraging neurodegenerative stress and immunoogenetic models from UTSW for antibody discovery.

Oct 26, 2023

Bright Minds

Breakfast at biolabs: OncoNano Medicine

Marty Driscoll describes how OncoNano is utilizing a tumor's acidic environment to develop therapies and imaging agents.

Breakfast at biolabs: Secretome Therapeutics

Oct 26, 2023

Bright Minds

Breakfast at biolabs: Secretome Therapeutics

Vinny Jindal describes Secretome's approach to using neonatal cardiac progenitor cells.

Everything you need to know about lipid nanoparticle delivery with UTSW's Dan Siegwart

Oct 25, 2023

Bright Minds

Everything you need to know about lipid nanoparticle delivery with UTSW's Dan Siegwart

Dan Siegwart describes what goes into getting LNPs to places in the body beyond the liver, and how he has co-founded ReCode Therapeutics.

Form Bio's Chief Strategy Officer on optimizing the payload of cell and gene therapies

Oct 25, 2023

Bright Minds

Form Bio's Chief Strategy Officer on optimizing the payload of cell and gene therapies

Claire Aldridge explains how Form Bio was derived from the work that Colossal Bio was doing in Texas.

UTSW's Eric Olson on using gene therapies and regenerative medicine for muscle disorders

Oct 25, 2023

Bright Minds

UTSW's Eric Olson on using gene therapies and regenerative medicine for muscle disorders

Dr. Olson describes work that has come out of his lab that aims to help diseases such as muscular dystrophy and hypertrophic cardiomyopathy.

UTSW's David Greenberg talks about trying to solve the problem of implant infections

Oct 24, 2023

Bright Minds

UTSW's David Greenberg talks about trying to solve the problem of implant infections

David Greenberg describes Solenic Medical's non-pharmaceutical solution to implant infections.

LH Capital’s Nicole Small gives an overview of the Dallas area biotech ecosystem

Oct 24, 2023

Bright Minds

LH Capital’s Nicole Small gives an overview of the Dallas area biotech ecosystem

Nicole Small describes the investments in infrastructure that are being made to grow entrepreneurs’ ability to keep science at home in DFW.

How MIT innovates with the Director of MIT’s Institute for Medical Engineering and Science

Oct 23, 2023

Bright Minds

How MIT innovates with the Director of MIT’s Institute for Medical Engineering and Science

Elazer Edelman explains how MIT acts as a bridge between the development of technology and the introduction of technology.

The CEO of Kano Therapeutics discusses circular single-stranded DNA, and life as a startup

Oct 20, 2023

Bright Minds

The CEO of Kano Therapeutics discusses circular single-stranded DNA, and life as a startup

Floris Engelhardt describes how Kano is trying to use circular single-stranded DNA to correct gene length stretches of the genome.

The CEO of GreenLight Biosciences talks about using RNA in agriculture

Oct 19, 2023

Bright Minds

The CEO of GreenLight Biosciences talks about using RNA in agriculture

Andrey Zarur says that GreenLight is the largest manufacturer of RNA in the wold.

Nextech Invest's Stella Paffenholz on finding opportunities during difficult markets

Oct 19, 2023

Bright Minds

Nextech Invest's Stella Paffenholz on finding opportunities during difficult markets

Stella Paffenholz says areas like gene editing, radiopharmaceuticals, and innovative small molecules make this an exciting time.

Action Potential Venture Capital's Imran Eba describes the field of bioelectronic medicine

Oct 19, 2023

Bright Minds

Action Potential Venture Capital's Imran Eba describes the field of bioelectronic medicine

Imran Eba explains the idea of aiming to treating any disease by stimulating or blocking nerve signals, an investment focus of his firm.

Genezen's CEO discusses the current supply situation in viral vector manufacturing

Oct 19, 2023

Bright Minds

Genezen's CEO discusses the current supply situation in viral vector manufacturing

Steve Favaloro explains why the industry is seeing shortages and what is being done by companies to boost supply.

Vida Ventures' Arjun Goyal shares his thoughts on the current environment in biotech

Oct 19, 2023

Bright Minds

Vida Ventures' Arjun Goyal shares his thoughts on the current environment in biotech

Arjun Goyal describes how firms are trying to navigate both the private and public markets in biotech today.

Canaccord Genuity’s Bill Maughan joins BiotechTV for Analyst Thursdays

Oct 19, 2023

Bright Minds

Canaccord Genuity’s Bill Maughan joins BiotechTV for Analyst Thursdays

Bill Maughan discusses Nkarta, ESMO news on Bicycle, BioNTech, Olema, and Xencor, and comments on iPSC companies, Immmunocore, and more.

Nobel laureate Carolyn Bertozzi walks us through the science of glyco-immunology

Oct 18, 2023

Bright Minds

Nobel laureate Carolyn Bertozzi walks us through the science of glyco-immunology

Dr. Bertozzi describes how types of cell surface glycans play a role in immune modulation and how Palleon is trying to drug them.

Evercore ISI’s Liisa Bayko joins BiotechTV for Analyst Thursdays

Oct 12, 2023

Bright Minds

Evercore ISI’s Liisa Bayko joins BiotechTV for Analyst Thursdays

Liisa Bayko discusses recent news from Astria Therapeutics, Alnylam, and Akero, and comments on 89bio, Madrigal, Altimmune, and more.

Follow BiotechTV

Sponsors

Sponsor Spotlight

Get in Touch

Advertise:

News coverage opportunities:

Contributors

Advertise@BiotechTV.com

MediaOppty@BiotechTV.com

Ali Gorman

Philadelphia Area

Brian Orelli

San Diego Area

General equiries and feedback:

BiotechTV U:

Info@BiotechTV.com

Universities@BiotechTV.com

Amy Brown

United Kingdom Area

Chris Garabedian

BioVenture VoiCes

Brad Loncar

Founder

Join our mail list

Disclosures & Policies